Equities

Meilleure Health International Industry Group Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Meilleure Health International Industry Group Ltd

Actions
  • Price (HKD)0.265
  • Today's Change0.017 / 6.85%
  • Shares traded696.00k
  • 1 Year change-8.62%
  • Beta0.5381
Data delayed at least 15 minutes, as of Feb 16 2026 03:57 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Meilleure Health International Industry Group Ltd is an investment holding company mainly engaged in the production and sale of cannabis health products. The Company operates through four segments. The Healthcare-Related Business segment is engaged in health management services, medical beauty services, and sales of health-related products and Cannabidiol (CBD) downstream products. The Property-Related Business segment is engaged in real estate sales agency, investment property leasing, and residential property development and sales. The Trading Business segment is engaged in the trading of building materials and new energy products, the provision of new energy product procurement services, and health-related product sales agency services. The Equity Investment Business segment is engaged in the management of investment portfolio.

  • Revenue in HKD (TTM)38.10m
  • Net income in HKD39.17m
  • Incorporated2002
  • Employees49.00
  • Location
    Meilleure Health International Industry Group LtdUnit 2906, Tower 1, Lippo Centre89 QueenswayAdmiralty Hong KongHKG
  • Phone+852 25631500
  • Fax+852 25631900
  • Websitehttp://www.meilleure.com.cn
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
2327:HKG since
announced
Transaction
value
Jiangsu Yide Investment Co LtdAnnounced08 Jan 202608 Jan 2026Announced-5.36%17.83m
Data delayed at least 15 minutes, as of Feb 16 2026 03:57 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.